期刊文献+

埃泼斯坦-巴尔病毒潜伏膜蛋白2A特异性细胞毒性T淋巴细胞的体外诱导研究

Induction of Epstein-Barr Virus Latent Membrane Protein 2A-Specific Cytotoxic T Lymphocytes in vitro
下载PDF
导出
摘要 目的:利用含埃泼斯坦-巴尔病毒(Epstein-Barr virus,EBV)潜伏膜蛋白2A重组痘苗病毒(rVV-LMP2A)感染的人树突状细胞(DC)体外诱导EBV-LMP2A特异性细胞毒性T淋巴细胞(CTL)。方法:rVV-LMP2A感染的DC分别在培养第1、8天刺激相同MHC背景的人外周血单个核细胞(PBMC),在IL-2作用下体外诱导EBV特异性CTL。培养第15天乳酸脱氢酶法检测CTL的特异性杀伤活性。结果:诱导的CTL对rVV-LMP2A感染的靶细胞在效靶比为5:1、10:1和15:1时,特异性杀伤率分别为63.5%、65.5%和67.9%。结论:rVV-LMP2A感染的DC刺激相同MHC背景的PBMC可诱导出较高杀伤活性的EBV特异性CTL。 Objective: To induce the specific cytotoxic T lymphocytes (CTL) in vitro using human monocyte-derived dendritic cells (DC) infected with recombinant vaccinia virus carrying Epstein-Barr virus latent membrane protein 2A (EBV-LMP2A) gene (rVV-LMP2A). Methods: With the treatment of IL-2, EBV-specific CTL was induced by coculture of rVV-LMP2A-infecting DC with the PBMC of identical donor. Specific cytotoxic competence of the CTL was measured by using lactate dehydrogenase (LDH) release assay. Results: The specific cytotoxicity of the CTL with the effect: target (E= T) ratio of 5- 1, 10: 1 and 15: 1 was 63. 5%, 65. 5% and 67. 9% respectively. Conclusion: The EBV-specific CTL can be efficiently induced by DC infected with rVV-LMP2A in vitro.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2003年第6期539-541,共3页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省科委"九五"重大课题(BJ98100)
关键词 树突状细胞 EB病毒潜伏膜蛋白2A 细胞毒性T淋巴细胞 dendritic cell Epstein-Barr virus latent membrane protein 2A cytotoxic T lymphocyte
  • 相关文献

参考文献5

二级参考文献19

  • 1林毓纯 商铭 等.鼻咽癌的细胞免疫及其HLA的限制[J].病毒学报,1982,4(4):254-256.
  • 2林毓纯 赵文革 等.鼻咽癌病人淋巴细胞对鼻咽癌上皮样细胞株(CNE)的体外细胞毒性反应[J].中华肿瘤杂志,1981,3(1):1-3.
  • 3Hu L F,Oncogene,1993年,8卷,1575页
  • 4杜滨,病毒学报,1987年,3卷,92页
  • 5曾毅,癌症,1982年,1卷,6页
  • 6Schneider J,Gilbert SC,Blanchard TJ,et al.Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara[].Nature Medicine.1998
  • 7Zhong L,Piperno AG,Choi Y,et al.Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendertic cells[].European Journal of Immunology.1999
  • 8Carroll MW,Overwijk WW,Chamberlain RS,et al.Highly attenuated modified vaccinia virus Ankara as an effective recombinant vector: a murine tumor model[].Vaccine.1997
  • 9Subklewe M,Chahroudi A,Schmaljohn A,et al.Induction of Epstein-Barr virus cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus[].Blood.1999
  • 10Arthur JF,Butterfield LH,Roth MD,et al.A comparison of gene trandfer methods in human dendritic cells[].Cancer Gene Therapy.1997

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部